Kukje Pharma Co (XKRX:002720) Interest Expense : ₩-1,206 Mil (TTM As of Dec. 2024)

View and export this data going back to 1975. Start your Free Trial

What is Kukje Pharma Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kukje Pharma Co's interest expense for the three months ended in Dec. 2024 was ₩ -252 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,206 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kukje Pharma Co's Operating Income for the three months ended in Dec. 2024 was ₩ 943 Mil. Kukje Pharma Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -252 Mil. Kukje Pharma Co's Interest Coverage for the quarter that ended in Dec. 2024 was 3.75. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kukje Pharma Co Interest Expense Historical Data

The historical data trend for Kukje Pharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kukje Pharma Co Interest Expense Chart

Kukje Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-650.13

-696.43

-1,000.49

-1,439.89

-1,205.91

Kukje Pharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-367.53	-357.40	-318.45	-278.26	-251.80

Kukje Pharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,206 Mil.

Kukje Pharma Co (XKRX:002720) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kukje Pharma Co's Interest Expense for the three months ended in Dec. 2024 was ₩-252 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩943 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩27,342 Mil.

Kukje Pharma Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	943.057	/	-251.796
	=	3.75

The higher the ratio, the stronger the company's financial strength is.

Kukje Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukje Pharma Co Ltd (XKRX:002720) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

96-8 Yatapiro, Bundang-Gu, Seongnam-si, Gyeonggi, KOR, 463-839

Website

http://www.kukjepharm.co.kr

Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antifungal and antiviral agents, and other antibiotics.

Kukje Pharma Co Headlines

No Headlines